The exciting thing about Provenge is not only the real survival advantage that it offers with minimal side effects, but that it is a proof of concept treatment that is heralding in the potential future of many other immunotherapies. Today, we have two new possible treatments in active phase 3 trials, Prostvac and Yervoy. [...]
Dr. Farid Fata, who owns Michigan Hematology Oncology which has six offices throughout Michigan in the cities of Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy and Oak Park is now out of jail, but he is on bail. Why am I even telling you about this, because as usual I have an important lesson to [...]
It has been brought to my attention that when I wrote the August 8, 2013 post on Pharma Sponsored Assistance Programs, I neglected to mention another excellent assistance program for men with advanced prostate cancer. The Chronic Disease Fund (CDF) has two funds that might be of specific interest to men with castrate resistant prostate [...]
Recently men with advanced prostate cancer have found that their insurance companies have been dictating what drugs they can get instead of their doctor making the best decision for them. At Malecare we have seen that when a man with metastatic castrate resistant prostate cancer (mCRPC) has finished taking chemotherapy they have been steered by [...]
I received an email from a lady from Australia that I though would be informative to share. It discusses genetic links and risk factors for hormonally related (including prostate) cancers: HER EMAIL TO ME Hi there :) I hope you don't mind me emailing you? I'm a lady from Australia and have 3 uncles with [...]